Researchers from Rush University have Identified Antihypertensive Drugs that Facilitate and/or Prevent Diabetes//.
Patients with high blood pressure are more likely to develop new-onset diabetes than those who don’t have hypertension, but this tendency is often attributed to higher weight, recent weight gain, or stronger family history of diabetes among those with high blood pressure.
Doctors have known since 1958 that some drugs used to control high blood pressure have the side effect of increasing blood sugar and causing new-onset diabetes.
Researchers at Rush University Medical Center analyzed the data from all of the randomized clinical trials (in which the assignment of initial drugs is based solely on chance, thus balancing the groups regarding other risk factors for diabetes), and have found significant differences between antihypertensive drugs. ACE-inhibitors and the newer angiotensin receptor blockers, or ARBs prevent people from getting diabetes, and the older diuretics or beta-blockers, increase the chance that a person becomes diabetic, compared to either placebo (inactive sugar-pills) or calcium channel blockers according to a study published in the January 20, 2007 issue of The Lancet.
Rush Preventive Medicine professor Dr. William J. Elliott, and Peter Meyer, Ph.D., director of the Section of Biostatistics, analyzed 22 long-term randomized clinical trials of each class of antihypertensive drugs, including placebo (inactive sugar-pills), to assess the chance that a person would develop diabetes during about 5 years of observation. The studies included 143,153 patients, and took place from 1966 through mid-September of 2006.
Their novel method of combining all the information available from clinical trials found that the lowest risk of new-onset diabetes occurred with ARBs or ACE-inhibitors, followed by calcium channel blockers or placebo (both of which were relatively neutral), and highest with beta
'"/>Page: 1 2 3 Related medicine news :1.
Differences in brain pattern among liars and cheats in comparison to honest people2.
Functional Differences In Estrogen Receptor Could Be A Therapeutic Target3.
Ethnic Differences in Healthcare4.
Ethnic Variations in Hormone Levels May Cause Differences in Breast Cancer Risk5.
Wide Differences between NHS staff and ministers 6.
Diminishing Differences and Empowering Eves7.
Biological Differences in Breast Cancer8.
Link Between Infection And Heart Disease9.
Prescription Drug Use Varies Widely Between States10.
Wait Between Pregnancies11.
Link Between Migraines and Behavioral Disorders